OpenAI Acquires Orchestra Bio to Enhance Drug Development Tools
OpenAI has acquired Orchestra Bio, a startup specializing in AI agents for biopharma operations. The company plans to integrate Orchestra's technology into its Rosalind life sciences suite to accelerate drug discovery workflows.
Checked against 4 sourcesTechCrunchOpenAItradingview.com+1 more
